Measurement of Early and Late Repolarization Periods in Addition to QT Interval to Help Predict the Torsadogenic Risk of Donepezil Based on Reverse Translational Animal Research on Its Proarrhythmic Potential-Reference-Cited by-同舟云学术

Measurement of Early and Late Repolarization Periods in Addition to QT Interval to Help Predict the Torsadogenic Risk of Donepezil Based on Reverse Translational Animal Research on Its Proarrhythmic Potential

Published:2021-09-10 Issue:9 Volume:3 Page:555-556
ISSN:2434-0790
Container-title:Circulation Reports
language:en
Short-container-title:Circ Rep

Author:

Kambayashi Ryuichi¹,Goto Ai¹,Izumi-Nakaseko Hiroko¹,Matsumoto Akio²,Sugiyama Atsushi¹

Affiliation:

1. Department of Pharmacology, Faculty of Medicine, Toho University

2. Department of Aging Pharmacology, Faculty of Medicine, Toho University

Publisher

Japanese Circulation Society

Subject

Marketing,Organizational Behavior and Human Resource Management,Strategy and Management,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.jstage.jst.go.jp/article/circrep/3/9/3_CR-21-0061/_pdf

Reference14 articles.

1. 1. Suleyman T, Tevfik P, Abdulkadir G, Ozlem S. Complete atrioventricular block and ventricular tachyarrhythmia associated with donepezil. Emerg Med J 2006; 23: 641–642.

2. 2. Leitch A, McGinness P, Wallbridge D. Calculate the QT interval in patients taking drugs for dementia. BMJ 2007; 335: 557.

3. 3. Tanaka A, Koga S, Hiramatsu Y. Donepezil-induced adverse side effects of cardiac rhythm: 2 cases report of atrioventricular block and Torsade de pointes. Intern Med 2009; 48: 1219–1223.

4. 4. Takaya T, Okamoto M, Yodoi K, Hata K, Kijima Y, Nakajima H, et al. Torsades de pointes with QT prolongation related to donepezil use. J Cardiol 2009; 54: 507–511.

5. 5. Hadano Y, Ogawa H, Wakeyama T, Iwami T, Kimura M, Mochizuki M, et al. Donepezil-induced Torsades de pointes without QT prolongation. J Cardiol Cases 2013; 8: e69–e71.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Appraisal of ICH E14/S7B Q&As adopted in February 2022 using thorough QT/QTc study data for α4-integrin antagonist carotegrast methyl in Japanese healthy subjects;Journal of Pharmacological Sciences;2022-11